AI-enabled drug discovery to identify and validate novel NSCLC targets in under 12 months

Learn how Tempus and a life sciences partner apply AI to Tempus multimodal data to classify new patient subgroups,identify novel gene targets, and validate those targets in patient-derived organoids as an accelerated approach to AI-enabled oncology target discovery.

Sep 15, 2026
Life Sciences
Case Study

Related content

A white circle partially overlapping a solid white square against a dark background.Case Study
Scientific paper comparing therapies for BRAF mutated thyroid cancer with real world data.

Comparing first-line therapies in BRAF-mutated thyroid cancer using real-world data

2026-09-03
Life Sciences
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Abstract digital representation of genetic code with glowing circular data visualization.

Foundation models in pathology: How Virchow is accelerating precision drug development

2026-08-27
Life Sciences
Foundation Model
Digital Pathology
pFM
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Person works on computer with abstract digital code and data patterns overlayed.

Bridging the gap: How Target Trial Emulation transforms real-world data into credible evidence

2026-08-20
Life Sciences